S.Amdt. 1918Senate117th Congress (2021-2023)2nd degree
S.Amdt. 1918
Sponsored by
Sen. Dan Sullivan (R-AK)
Submitted May 20, 2021
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
May 20, 2021
Text
Submitted
SA 1918. Mr. SULLIVAN submitted an amendment intended to be proposed to amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes; which was ordered to lie on the table; as follows: At the end of subtitle B of title II of division E, add the following: SEC. 5214. DISCLOSURES REQUIRED BY UNITED STATES ENTITIES INVESTING IN THE CHINESE COMMUNIST PARTY OR THE PEOPLE'S LIBERATION ARMY. (a) In General.--The Director of the Office of Foreign Assets Control of the Department of the Treasury shall require any United States entity that makes an investment described subsection (b) to disclose the purpose and amount of such investments to the Director on an annual basis. (b) Investments Described.--An investment described in this subsection is a monetary investment, in an amount that exceeds an amount determined by the Director, directly or indirectly-- (1) to-- (A) the Chinese Communist Party; (B) an entity owned or controlled by the Chinese Communist Party; or (C) the People's Liberation Army; or (2) for the benefit of any key industrial sector championed by the Chinese Communist Party, including the following: (A) Information technology. (B) Artificial intelligence. (C) The internet of things. (D) Smart appliances. (E) Robotics. (F) Machine learning. (G) Energy. (H) Aerospace engineering. (I) Ocean engineering. (J) Railway equipment. (K) Power equipment. (L) New materials. (M) Pharmaceuticals. (N) Biomedicine. (O) Medical devices. (P) Agricultural machinery. (c) Consolidated Report.--Not less frequently than annually, the Director shall compile the disclosures submitted under subsection (a) and submit that compilation and a summary of those disclosures to-- (1) the Committee on Banking, Housing, and Urban Affairs and the Committee on Foreign Relations of the Senate; and (2) the Committee on Financial Services, the Committee on Energy and Commerce, and the Committee on Foreign Affairs of the House of Representatives. (d) Regulations.--The Director shall prescribe such regulations as are necessary to carry out this section, which may include-- (1) requirements for documents and information to be submitted with disclosures required under subsection (a); and (2) procedures for the determining the amount under subsection (b). (e) United States Entity Defined.--In this section, the term ``United States entity'' means an entity organized under the laws of the United States or of any jurisdiction within the United States, including a foreign branch of such an entity. ______